Wieshammer S, Hetzel M, Hetzel J, Kochs M, Hombach V
Department of Cardiology, University of Ulm, Germany.
Br Heart J. 1993 Jul;70(1):17-21. doi: 10.1136/hrt.70.1.17.
To test the hypothesis that the addition of nitrates improves exercise tolerance in patients with heart failure caused by coronary artery disease already treated with an angiotensin converting enzyme inhibitor and diuretics.
Randomised, double blind, placebo controlled, 16 week treatment periods.
Outpatient clinic at a university hospital.
54 patients with previous myocardial infarction, symptoms of mild to moderate heart failure, left ventricular ejection fraction below 40%, no exercise-induced angina or electrocardiographic signs of ischaemia. Four patients in the nitrate group (n = 24) and one patient of the placebo group (n = 25) were withdrawn from the study.
After the patients had been on constant doses of captopril and diuretics for at least 2 weeks, they were randomised to receive a target dose of 40 mg isosorbide dinitrate twice daily or placebo in addition to the continuation of captopril and diuretics.
Bicycle exercise tests with measurement of gas exchange were carried out before randomisation and after 1, 6, 12, and 16 weeks of the double blind treatment. The change in peak oxygen uptake from control to week 16 was prospectively defined as the main outcome measure.
The increase in peak oxygen uptake from before randomisation tended to be greater in the placebo group (before randomisation 17.4 (3.4) ml/min/kg) than in the nitrate group (before randomisation 17.1 (3.5) ml/min/kg) after 12 weeks (mean increase 1.1 (2.7) v 0.0 (2.7) ml/min/kg, p < 0.12) and 16 weeks (1.7 (3.0) v 0.3 (2.6) ml/min/kg, p < 0.14) of treatment.
The addition of nitrates to a baseline treatment consisting of captopril and diuretics did not improve exercise tolerance.
检验以下假设:对于已接受血管紧张素转换酶抑制剂和利尿剂治疗的冠心病所致心力衰竭患者,添加硝酸盐可提高运动耐量。
随机、双盲、安慰剂对照,治疗期为16周。
大学医院门诊。
54例曾患心肌梗死、有轻至中度心力衰竭症状、左心室射血分数低于40%、无运动诱发心绞痛或缺血性心电图表现的患者。硝酸盐组(n = 24)有4例患者和安慰剂组(n = 25)有1例患者退出研究。
患者在接受至少2周的卡托普利和利尿剂恒定剂量治疗后,除继续使用卡托普利和利尿剂外,被随机分配接受每日两次40毫克二硝酸异山梨酯的目标剂量或安慰剂。
在随机分组前以及双盲治疗1、6、12和16周后进行测量气体交换的自行车运动试验。从对照到第16周的峰值摄氧量变化被前瞻性地定义为主要结局指标。
在治疗12周(平均增加1.1(2.7)对0.0(2.7)毫升/分钟/千克,p<0.12)和16周((1.7(3.0)对0.3(2.6)毫升/分钟/千克,p<0.14)后,安慰剂组从随机分组前开始的峰值摄氧量增加趋势大于硝酸盐组(随机分组前17.4(3.4)毫升/分钟/千克)。
在由卡托普利和利尿剂组成的基线治疗中添加硝酸盐并不能提高运动耐量。